Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
Recruiting
Phase 1
Phase 2
Interventional Study
Helicobacter Pylori Infection
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 30 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Current guidelines mandate Helicobacter pylori (H. Pylori) eradication with 2-3 antibiotics for 14 days ,This may result in multiple side effects and in eradication of important bacterial species to human health, exposing humans to multiple disease conditions.
Preservation of fecal microbiome prior to antibiotic therapy and auto-transplantation of the microbes post H. pylori eradication, will ena…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-70 years old
* Positive H. pylori on either breath test or gastric biopsy
* Patient is intended to receive antibiotics therapy for H. pylori eradication
Exclusion Criteria:
* Severe systemic disease that may impact the microbiome. For example: heart disease, type two …
Contacts